Home > News > NCL to go into labs with ‘Golden Triangle’ for cancer trials
May 30th, 2005
NCL to go into labs with ‘Golden Triangle’ for cancer trials
Eight months after raising hopes with their cutting edge ‘Golden Triangle’ technology for fighting cancer sans chemotherapy, nanoscientists at the National Chemical Laboratory (NCL) are gearing up for the technology’s first in-vitro tests.
The trials are being conducted to establish the toxicity of the gold nano-particles. "While gold is inherently non-toxic, we have to see exactly where the nano-sized triangles go when introduced into the cancerous area. We have kept a two-year window to see if we can get into clinical trials on humans."
National Chemical Laboratory
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014
SentiMag® Now Available in Australia and New Zealand July 21st, 2014
More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014
Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014
A Crystal Wedding in the Nanocosmos July 23rd, 2014